JosephALaskyMD
Pulmonology • New Orleans, LACritical Care Medicine, Pleural Disease
Professor, Medicine, Tulane University School of Medicine
Dr. Lasky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1415 Tulane Ave
# TW24
New Orleans, LA 70112Phone+1 504-988-8600Fax+1 504-988-8629
Summary
- Dr. Joseph Lasky is a pulmonologist in New Orleans, LA and is affiliated with Tulane Health System. He received his medical degree from University of Minnesota Medical School and has been in practice 32 years. He specializes in pleural disease and is experienced in interstitial lung disease, critical care medicine, and general pulmonology.
Education & Training
Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1985 - 1988
University of Minnesota Medical SchoolClass of 1985
Certifications & Licensure
LA State Medical License 1993 - 2025
NC State Medical License 1992 - 1999
MN State Medical License 1986 - 1989- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012
Clinical Trials
- Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study Start of enrollment: 2003 Apr 01
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
- Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial Start of enrollment: 2020 Dec 17
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- Gammaherpesvirus Infection Stimulates Lung Tumor-Promoting Inflammation.Sudurika S Mukhopadhyay, Kenneth F Swan, Gabriella Pridjian, Jay K Kolls, Yan Zhuang
Pathogens. 2024-08-31 - 18 citationsMeaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Sympo...Ganesh Raghu, Marya Ghazipura, Thomas R Fleming, Kerri I Aronson, Jürgen Behr
American Journal of Respiratory and Critical Care Medicine. 2024-03-15 - Enhanced Expression of a Novel Lamin A/C Splice Variant in Idiopathic Pulmonary Fibrosis Lung.Qinyan Yin, Gilbert F Morris, Shigeki Saito, Yan Zhuang, Victor J Thannickal
American Journal of Respiratory Cell and Molecular Biology. 2023-06-01
Press Mentions
Veracyte Expands Early Access to Envisia Genomic Classifier Test for IPF DiagnosisDecember 10th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
